Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Submitted by
admin
on April 1, 2017 - 8:03am
Source:
Mass Device
News Tags:
Acorda Therapeutics
Parkinson's Disease
CVT-301
Levodopa
Headline:
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Do Not Allow Advertisers to Use My Personal information
